Posted by Chairman_MAO on October 21, 2005, at 0:18:18
In reply to Re: Triple reuptake inhibitors and MAOIs, posted by SLS on October 20, 2005, at 19:24:56
I feel that drug companies come out with single-entianomer drugs because it's cheaper than R&D, plain and simple. Why develop a totally new drug--even if it helps more people, is simply better, etc--when you can re-patent an entianomer?
poster:Chairman_MAO
thread:568913
URL: http://www.dr-bob.org/babble/20051017/msgs/569693.html